The “young-to-aged” paradigm: fantasy or feasible strategy for cardiovascular and systemic rejuvenation?

Abstract

The “young-to-aged” paradigm represents a long existing postulation that rejuvenation in aged individuals can be achieved by replacing components such as cells, tissues, or organs with young counterparts. While highly publicized human plasma exchange trials show conflicting results, preclinical studies in mice demonstrate promising yet partial functional rejuvenation, including enhanced mitochondrial metabolism, reduced neurodegeneration, and revitalized stem cells via transfer of young biological components (e.g., plasma and microbiota). Importantly, certain critical studies have demonstrated that the “young-to-aged” paradigm could achieve partial cardiovascular rejuvenation in murine models. For instance, exposure to young plasma represses cardiac hypertrophy, while exposure to young microbiota alleviates vascular dysfunction and systemic inflammation. However, significant challenges still persist, including ethical concerns, the irreversibility of aging beyond certain thresholds, and senescence propagation of young donor transplants due to aged recipient environments. This paradigm faces immense scientific and ethical hurdles, raising profound questions about feasibility and identity.

Keywords

Anti-aging / cardiovascular aging / ethical concern / gut microbiota / plasma transfusion / rejuvenation / tissue replacement

References

[1] Fuentealba M,Schneider K.Multi-omics analysis reveals biomarkers that contribute to biological age rejuvenation in response to single-blinded randomized placebo-controlled therapeutic plasma exchange.Aging Cell2025;24:e70103

[2] Ma S,Ye Y.Heterochronic parabiosis induces stem cell revitalization and systemic rejuvenation across aged tissues.Cell Stem Cell2022;29:990-1005.e10

[3] Chen X,Zhu Q.Small extracellular vesicles from young plasma reverse age-related functional declines by improving mitochondrial energy metabolism.Nat Aging2024;4:814-38 PMCID:PMC11186790

[4] Middeldorp J,Villeda SA.Preclinical assessment of young blood plasma for alzheimer disease.JAMA Neurol2016;73:1325-33 PMCID:PMC5172595

[5] Ximerakis M,Giadone RM.Heterochronic parabiosis reprograms the mouse brain transcriptome by shifting aging signatures in multiple cell types.Nat Aging2023;3:327-45 PMCID:PMC10154248

[6] Wang Y,Zhang C,Seino T.Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice.Cell Res2025;35:45-58 PMCID:PMC11701126

[7] Chen LJ,Wang Y.Single xenotransplant of rat brown adipose tissue prolonged the ovarian lifespan of aging mice by improving follicle survival.Aging Cell2019;18:e13024 PMCID:PMC6826128

[8] Mason JB,Griffey SM,Anderson GB.Transplantation of young ovaries restored cardioprotective influence in postreproductive-aged mice.Aging Cell2011;10:448-56 PMCID:PMC3102294

[9] Loffredo FS,Jay SM.Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.Cell2013;153:828-39 PMCID:PMC3677132

[10] Basson M.Young blood helps the heart.Nat Med2013;19:682-682

[11] Kiss T,Csipo T.Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood.Geroscience2020;42:727-48 PMCID:PMC7205954

[12] Gulej R,Csik B.Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: enhancing blood-brain barrier integrity and capillarization in the aged mouse brain.Geroscience2024;46:4415-42 PMCID:PMC11336025

[13] Clarke G,Kennedy PJ,Cryan JF.Minireview: gut microbiota: the neglected endocrine organ.Mol Endocrinol2014;28:1221-38 PMCID:PMC5414803

[14] Zeng X,Li X.Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation.Blood2023;141:1691-707 PMCID:PMC10646769

[15] Parker A,Ansorge R.Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain.Microbiome2022;10:68

[16] Cheng CK,Kang L.Fecal microbiota transfer from young mice reverts vascular aging hallmarks and metabolic impairments in aged mice.Aging Dis2024;16:1576-85 PMCID:PMC12096931

[17] Cheng CK,Meng S.The pro-aging and rejuvenating effects of young and aged perivascular adipose tissues on endothelial function and inflammation.Biogerontology2025;26:134

[18] Lau A,Kirkland JL.Mixing old and young: enhancing rejuvenation and accelerating aging.J Clin Invest2019;129:4-11

[19] Dayoub JC,Anžič A,de Magalhães JP.The effects of donor age on organ transplants: a review and implications for aging research.Exp Gerontol2018;110:230-40 PMCID:PMC6123500

[20] Cheng CK,Zuo Y.Aged gut microbiome induces metabolic impairment and hallmarks of vascular and intestinal aging in young mice.Antioxidants2024;13:1250 PMCID:PMC11505429

[21] Mei X,Luellen C,Conboy IM.Fail-tests of DNA methylation clocks, and development of a noise barometer for measuring epigenetic pressure of aging and disease.Aging2023;15:8552-75 PMCID:PMC10522373

[22] López-Otín C,Partridge L,Kroemer G.Hallmarks of aging: an expanding universe.Cell2023;186:243-78